ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Recs

0
Player Avatar mdriver78 (< 20) Submitted: 2/7/2012 8:48:20 AM : Underperform Start Price: $30.95 VPHM Score: -3.07

FDA strikes again!

Featured Broker Partners


Advertisement